FINWIRES · TerminalLIVE
FINWIRES

Starpharma Says US FDA Supports First-in-Human Study of Cancer Radiotherapy Candidate; Shares Gain 7%

By

-- Starpharma Holdings (ASX:SPL) has received positive feedback from the US Food and Drug Administration (FDA) on the proposed design of its first-in-human phase 1 clinical study of the DEP HER2 radiotherapy candidate, according to a Tuesday filing with the Australian bourse.

The company is developing the candidate to treat certain gastric/gastro-oesophageal junction cancers and other advanced cancers in patients who have previously received targeted therapy.

The US FDA feedback supports plans to launch the phase one study, which is on track to begin in the second half of the year.

The FDA also confirmed that the radiotherapy candidate is targeting a population with a significant unmet medical need, indicating the potential for a fast-track designation or other accelerated development pathways, Starpharma said.

The company's shares were 7% higher in recent Tuesday trade.

Related Articles

Asia

StanChart Buys Back Shares

Standard Chartered (HKG:2888) bought back 849,232 shares on Monday at an average price of 17.57 pounds sterling apiece, according to a Tuesday Hong Kong bourse filing.The British lender plans to cancel the shares, following which it will have about 2.22 billion shares in issue.

$HKG:2888
Asia

Prudential Buys Back Shares

Prudential (SGX:K6S, HKG:2378) bought back 449,197 shares in London on Monday at an average price of about 11.24 pounds sterling apiece, according to a Tuesday Hong Kong bourse filing.The insurer intends to cancel the repurchased shares.Following the transaction, the company will have about 2.52 billion shares in issue.

$HKG:2378$SGX:K6S
Asia

South Korean Shares Hit New High as Investors Eye US Q1 Tech Earnings

South Korean shares closed at a fresh new high on Tuesday, as investors looked forward to the first-quarter earnings of key US-based technology companies.The Korea Composite Stock Price Index or Kospi rose 25.99 points, or 0.4%, to end at 6,641.02. The Kosdaq decreased by 10.6 points, or 0.9%, to close at 1,215.58.In economic news, the composite business sentiment index in all industries in South Korea increased 0.8 points to 94.9 in April from 94.1 in March, while the outlook for the next month added 0.8 points to 93.9, according to data released by the Bank of Korea on Tuesday.The outlook for May marked the highest level since August 2024.Meanwhile, the economic sentiment index, a composite of the business survey and consumer survey indices, went down 2.3 points to 91.7.In corporate news, DoubleU Games (KRX:192080) will acquire all issued and outstanding American Depositary Shares (ADS) of DoubleDown Interactive at $11.25 per ADS in cash, the developer of online games and mobile games said Tuesday.The deal is valued at about $184 million. Following the transaction, DoubleDown Interactive will become a fully-owned subsidiary of DoubleU Games, according to the release.Shares of DoubleU Games jumped nearly 9% at market close.

$^KOSDAQ$^KS11$KRX:192080